Source: FinanzNachrichten

BIOLAB: QUANTUM GENOMICS: Quantum Genomics and Biolab Sanus Pharmaceutical Enter into Exclusive Licensing and Collaboration Agreement for Firibastat in Latin America

Biolab Sanus Pharmaceutical to receive an exclusive license to develop and commercialize firibastat for the treatment of arterial hypertension in Latin America Quantum Genomics (Euronext Growth - ...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100